UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

Annals of oncology, 2017-10, Vol.28 (10), p.2539-2546

2017

Volltextzugriff (PDF)

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes

Annals of oncology, 2016-07, Vol.27 (7), p.1336-1341

2016

Volltextzugriff (PDF)

Pan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

Annals of oncology, 2018-10, Vol.29, p.viii17-viii17

2018

Volltextzugriff (PDF)

Comprehensive genomic profiling (CGP) of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors (PMNSGCT)

Annals of oncology, 2018-10, Vol.29, p.viii305-viii305

2018

Volltextzugriff (PDF)

Recurrent and metastatic carcinomas of the lacrimal gland: High frequency of ERBB2 driven disease

Annals of oncology, 2018-10, Vol.29, p.viii47-viii48

2018

Volltextzugriff (PDF)

Comprehensive genomic profiling (CGP) of thymic gland carcinomas

Annals of oncology, 2017-11, Vol.28, p.x166-x166

2017

Volltextzugriff (PDF)

Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

Gynecologic oncology, 2016-10, Vol.143 (1), p.208-209

2016

Volltextzugriff (PDF)

BRAF genomic alterations in breast cancer

Annals of oncology, 2016-10, Vol.27, p.vi70-vi70

2016

Volltextzugriff (PDF)

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

Annals of oncology, 2016-10, Vol.27, p.vi329-vi329

2016

Volltextzugriff (PDF)

Comprehensive genomic profiling of 8,654 breast carcinoma reveals therapeutically targetable molecular subtypes beyond those defined by hormone-receptor expression

Annals of oncology, 2016-10, Vol.27, p.vi70-vi70

2016

Volltextzugriff (PDF)

Comprehensive genomic profiling of uterine carcinosarcomas identifies potential targeted therapy opportunities

Annals of oncology, 2016-10, Vol.27, p.vi308-vi308

2016

Volltextzugriff (PDF)

Uterine Carcinosarcoma: Molecular Profiling and Identification of Possible Therapeutic Targets

Gynecologic oncology, 2016-10, Vol.143 (1), p.199-200

2016

Volltextzugriff (PDF)

Advanced acinic cell carcinoma harbors kinase rearrangements including BRAF kinase domain duplications

Annals of oncology, 2016-10, Vol.27, p.vi338-vi338

2016

Volltextzugriff (PDF)

Pathogenesis of Langerhans cell histiocytosis

Annual review of pathology, 2013-01, Vol.8 (1), p.1-20

2013

Volltextzugriff (PDF)

Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC)

European urology open science (Online), 2020-07, Vol.19, p.e1665-e1666

2020

Volltextzugriff (PDF)

Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

Blood cancer journal (New York), 2015-02, Vol.5 (2), p.e278-e278

2015

Volltextzugriff (PDF)

Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation

The Journal of biological chemistry, 1993-06, Vol.268 (16), p.11951-11958

1993

Volltextzugriff (PDF)

P1.14-46 Genomic Profiling of Large Cell Neuroendocrine Carcinomas of Lung: A Path Towards Individualized Treatment Options

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S573-S573

2019

Volltextzugriff (PDF)

2001P Adenoid cystic carcinomas (ACC) of the trachea, salivary gland, breast: A comparative comprehensive genomic profiling (CGP) study

Annals of oncology, 2020-09, Vol.31, p.S1117-S1118

2020

Volltextzugriff (PDF)

787P Urachal (URAC) and non-urachal (NURAC) adenocarcinomas of the urinary bladder: A comparative comprehensive genomic profiling (CGP) study

Annals of oncology, 2020-09, Vol.31, p.S600-S601

2020

Volltextzugriff (PDF)

957P Ameloblastoma of the head and neck (HNAMB): A comprehensive profiling (CGP) study

Annals of oncology, 2020-09, Vol.31, p.S677-S678

2020

Volltextzugriff (PDF)

Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis

American journal of clinical pathology, 2007-04, Vol.127 (4), p.642-650

2007

Volltextzugriff (PDF)

PALB2 reversion mutations in breast, prostate, and ovarian carcinomas

Annals of oncology, 2017-09, Vol.28, p.v23-v24

2017

Volltextzugriff (PDF)

512O - Malignant non-adrenal paraganglioma (mPara) and adrenal pheochromocytoma (mPheo) a comparative comprehensive genomic profiling (CGP) study

Annals of oncology, 2019-10, Vol.30, p.v194-v194

2019

Volltextzugriff (PDF)

Malignant non-adrenal paraganglioma (mPara) and adrenal pheochromocytoma (mPheo) a comparative comprehensive genomic profiling (CGP) study

Annals of oncology, 2019-10, Vol.30, p.v194

2019

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(72)
Humans
(53)
Female
(33)
Male
(30)
Middle Aged
(30)
Adult
(28)
Aged
(25)
Mutation
(21)
Oncology
(21)
Adolescent
(17)
Young Adult
(16)
Aged, 80 And Over
(15)
Biological And Medical Sciences
(15)
Comprehensive Genomic Profiling
(14)
Hematology
(13)
Genomics
(11)
Hematology, Oncology And Palliative Medicine
(10)
Medical Sciences
(10)
Animals
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(38)
Journal Of Clinical Oncology
(26)
Blood
(23)
Cancer Research
(12)
The Oncologist
(6)
The oncologist
(6)
Cancer
(4)
European Journal Of Cancer
(4)
Gynecologic Oncology
(4)
Archivos Latinoamericanos De Nutrición
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes

Pan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

Comprehensive genomic profiling (CGP) of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors (PMNSGCT)

Recurrent and metastatic carcinomas of the lacrimal gland: High frequency of ERBB2 driven disease

Comprehensive genomic profiling (CGP) of thymic gland carcinomas

Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

BRAF genomic alterations in breast cancer

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

Comprehensive genomic profiling of 8,654 breast carcinoma reveals therapeutically targetable molecular subtypes beyond those defined by hormone-receptor expression

Comprehensive genomic profiling of uterine carcinosarcomas identifies potential targeted therapy opportunities

Uterine Carcinosarcoma: Molecular Profiling and Identification of Possible Therapeutic Targets

Advanced acinic cell carcinoma harbors kinase rearrangements including BRAF kinase domain duplications

Pathogenesis of Langerhans cell histiocytosis

Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC)

Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation

P1.14-46 Genomic Profiling of Large Cell Neuroendocrine Carcinomas of Lung: A Path Towards Individualized Treatment Options

2001P Adenoid cystic carcinomas (ACC) of the trachea, salivary gland, breast: A comparative comprehensive genomic profiling (CGP) study

787P Urachal (URAC) and non-urachal (NURAC) adenocarcinomas of the urinary bladder: A comparative comprehensive genomic profiling (CGP) study

957P Ameloblastoma of the head and neck (HNAMB): A comprehensive profiling (CGP) study

Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis

PALB2 reversion mutations in breast, prostate, and ovarian carcinomas

512O - Malignant non-adrenal paraganglioma (mPara) and adrenal pheochromocytoma (mPheo) a comparative comprehensive genomic profiling (CGP) study

Malignant non-adrenal paraganglioma (mPara) and adrenal pheochromocytoma (mPheo) a comparative comprehensive genomic profiling (CGP) study

Suchergebnisse filtern